Every material Form 8-K BUDA JUICE, INC. has filed with the SEC since January 09, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Buda Juice reported first quarter 2026 results for the quarter ended March 31, 2026. Revenue rose 17.7% year over year to $3.5 million, but operating income fell to $0.6 million from $0.8 million and GAAP net income fell to $0.4 million from $0.8 million, with the company citing a temporary spike in lime costs that pressured gross margin.
Revenue increased 17.7% to $3.5 million from $3.0 million; gross profit rose 3.5% to $1.4 million
Operating income fell to $0.6 million from $0.8 million; net income was $0.4 million versus $0.8 million, with diluted EPS of $0.03
Non-GAAP net income was $0.6 million, flat with the prior year, and non-GAAP EPS was $0.05
Free cash flow was $1.1 million, up 37% from the prior-year period; subsequent to quarter end, Buda Fresh Cherry Limeade expanded into 246 Walmart stores across nine states
Buda Juice said the underwriter of its initial public offering, MDB Capital, exercised its over-allotment option in full on January 21, 2026, and the offering has now closed. The extra 399,999 shares brought gross proceeds to approximately $23.0 million before underwriting discounts, commissions, and offering expenses, so the company receives about $3.0 million more from the offering than it would have without the option.
Additional gross proceeds from the over-allotment option: $2,999,992.50 for 399,999 shares before discounts, commissions, and expenses
Total shares sold in the offering: 3,066,666 at $7.50 per share, for approximately $23.0 million gross proceeds
The offering has closed; shares began trading on NYSE American under BUDA on January 8, 2026
Buda Juice, Inc. priced its initial public offering of 2,666,667 common shares at $7.50 per share, for $20 million in gross proceeds before underwriting discounts and expenses. Shares began trading on the NYSE American under the ticker BUDA on January 8, 2026. The company said it will use the net proceeds to develop production plants in South Carolina and Arizona/Nevada, expand its Dallas plant, support in-store marketing and provide working capital.
2,666,667 shares offered at $7.50 per share, for $20 million in gross proceeds to the company
Underwriter MDB Capital received warrants for 266,667 shares, exercisable from July 7, 2026 to January 7, 2031 at $9.375 per share
Underwriters also hold a 45-day option to buy up to 400,000 additional shares to cover over-allotments, if any
Board-approved 2025 Equity Incentive Plan adopted January 7, 2026 for employees, directors and consultants
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every BUDA JUICE, INC. filing is on SEC EDGAR ↗. 8-K briefs of other companies →